Hello again dear readers! You might have seen this in the news lately, but if not check it out!
A group of Italian scientists recently announced the discovery of two new phytocannabinoids: THCP and CBDP.
THCP may be more than 30 times more potent in its binding activity with CB1 receptors than THC, as well as being 5-10 times more potent in its binding activity with CB2 receptors. Whether it is psychoactive or not remains unknown.
CBDP is a cousin to our well-known friend CBD, and displays many similar anti-inflammatory, anti-epileptic, and anti-oxidant properties.
This discovery is another piece towards more thoroughly understanding why some strains of cannabis have different effects than others, based on their total phytocannabinoid profile. In turn, this greater understanding will allow people to more effectively use cannabis to treat their particular conditions as they learn which phytocannabinoid ratios to pursue.
I wanted to share this information in light of our recent post on some of the most pharmacologically active phytocannabinoids found in cannabis.
This discovery follows up on last year's discovery of CBDB and THCB.
I suspect as more resources are devoted to cannabis research and out-dated restrictions and modes of thinking are removed as barriers, we will be seeing a torrent of incredible medical cannabis discoveries.
Exciting times are ahead!